![Christopher Lai](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Lai
Chief Executive Officer at
METIS TECHBIO CO., LTD.
Net worth: 289 M $ as of 29/06/2026
Profile
Dr. Christopher Lai is a Chairman & Chief Executive Officer at Metis TechBio Co., Ltd., a General Manager & Executive Director at Metis Pharmaceuticals and a Chief Executive Officer at METiS Therapeutics, Inc. He is on the Board of Directors at Metis Pharmaceuticals.
Dr. Lai was previously employed as a Chief Technology Officer by AquaFresco, Inc.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 09/06/2026 | 111,166,572 ( 10.26% ) | 218 M $ | 29/06/2026 | |
METIS TECHBIO CO., LTD. 36.55% | 12/05/2026 | 36,400,278 ( 36.55% ) | 71 M $ | 29/06/2026 |
Christopher Lai active positions
| Companies | Position | Start |
|---|---|---|
| METIS TECHBIO CO., LTD. | Chief Executive Officer | 09/01/2020 |
METiS Therapeutics, Inc.
 METiS Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for patients with diseases | Chief Executive Officer | - |
Former positions of Christopher Lai
| Companies | Position | End |
|---|---|---|
AquaFresco, Inc.
 AquaFresco, Inc. Industrial MachineryProducer Manufacturing Designs and develops water recycling technology | Founder | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
14
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
AquaFresco, Inc.
AquaFresco, Inc. Industrial MachineryProducer Manufacturing Designs and develops water recycling technology | Producer Manufacturing |
METiS Therapeutics, Inc.
METiS Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for patients with diseases | Health Technology |
Hangzhou Jitai Pharmaceutical Technology Co. Ltd.
 Hangzhou Jitai Pharmaceutical Technology Co. Ltd. Chemicals: Major DiversifiedProcess Industries Operates as an investment holding company whose subsidiaries provides AI based nanomaterials delivery and application services | Process Industries |
- Stock Market
- Insiders
- Christopher Lai
